RICHESSE™ Filler Line Expansion!
Introducing ‘Ultra’, ‘Aqua Prime’ and the practical 2-syringe type!
Plus, a renewed and upgraded formula! 💉
JDBIO’s flagship brand RICHESSE™ has strengthened its lineup with newly upgraded versions of existing products, the all-new ‘Ultra’ and ‘Aqua Prime’, and a cost-effective 2-syringe type. This expansion goes beyond just launching new products — it marks a significant step toward solidifying RICHESSE™ as a brand offering diverse and tailored filler solutions.
✔ New Lineup Highlights
1️⃣ RICHESSE™ Ultra – Long-lasting Volume & High Definition
With high elasticity and viscosity, RICHESSE™ Ultra is ideal for contouring and treating deep wrinkles. It delivers natural yet well-defined results immediately after treatment, making it a perfect choice for those seeking a sculpted facial appearance.
2️⃣ RICHESSE™ Aqua Prime – Natural Volume & Hydration
RICHESSE™ Aqua Prime features a soft texture and low viscosity, designed for thin or sensitive areas such as around the eyes and lips. It provides a gentle, hydrating fill that blends seamlessly for high patient satisfaction.
3️⃣ 2-Syringe Type – Practical, Efficient, and Cost-Effective!
Another highlight is the new 2-syringe pack — each box includes two 1cc syringes, making it a smart and economical option for multiple or repeated treatments across different areas.
✔ What’s New in the Upgraded RICHESSE™
The premium RICHESSE™ line has been upgraded for even safer and more effective use.
🔹 BDDE-Free Purity – Formulated without impurities for a purer solution
🔹 HTL France Raw Materials – Trusted European-sourced ingredients
🔹 Cannula Included – Added convenience and ease of procedure
With this expanded lineup, RICHESSE™ is evolving from a simple filler brand into a provider of personalized aesthetic solutions, tailored to different skin types and treatment goals. Continued R&D and a commitment to quality will drive the brand’s growing influence in the global medical beauty market.
Stay tuned for more from RICHESSE™ – the future of aesthetic innovation.